GeneDx Holdings (WGSWW) Amortization of Deferred Charges (2021 - 2023)

GeneDx Holdings has disclosed Amortization of Deferred Charges across 3 years of filings, most recently posting $130000.0 for Q3 2023.

• In Q3 2023, Amortization of Deferred Charges changed 0.0% year-over-year to $130000.0; the TTM figure through Sep 2023 stood at $518000.0 (up 14.35% YoY), while the FY2022 annual figure was $518000.0, up 684.85% from the prior year.
• Amortization of Deferred Charges rose to $130000.0 in Q3 2023, from $129000.0 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for WGSWW reached as high as $131000.0 in Q4 2022 and fell as low as $66000.0 in Q4 2021.
• The 3-year median for Amortization of Deferred Charges is $129000.0 (2022), against an average of $121375.0.
• Annual changes were most pronounced in 2022 — Amortization of Deferred Charges soared 98.48% — and 2023, when it changed 0.0%.
• A 3-year view of Amortization of Deferred Charges shows it stood at $66000.0 in 2021, then soared by 98.48% to $131000.0 in 2022, then decreased by 0.76% to $130000.0 in 2023.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $130000.0, $129000.0, and $128000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.